ASCEND BY NTHRYS
Research Abroad Products

Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 85–96 of 2250 project topics
High-Throughput Therapeutic Target Screening and Ranking Tool
An automated workflow platform that screens thousands of genomic candidates against druggability, safety, and market criteria using proprietary algorithms and integrated databases. Delivers prioritized target shortlists in weeks rather than months, commanding premium pricing for accelerated drug discovery timelines.
Genomics Drug Target Discovery Service Platforms Click to view more details →
Whole Genome Bisulfite Sequencing Analysis
Processing WGBS data using Bismark and DSS for generating base-resolution DNA methylation maps and identifying differentially methylated regions.
Epigenomics and Chromatin Analysis Click to view more details →
Hi-C Data Analysis for 3D Genome Organization
Processing Hi-C sequencing data using Juicer and HOMER for generating contact matrices and identifying TADs, compartments, and loops.
Epigenomics and Chromatin Analysis Click to view more details →
Population Genomics-Based Drug Target Mining Service
A bioanalytical service platform leveraging large-scale population genomics datasets to identify novel genetic associations with disease and uncover undrugged targets with strong human validation. Generates recurring revenue through tiered subscriptions and custom analysis projects for pharmaceutical and biotech clients.
Genomics Drug Target Discovery Service Platforms Click to view more details →
CpG Methylation Pattern Detection and Commercial Reporting
SaaS platforms analyze DNA methylation patterns across CpG islands to identify disease biomarkers and generate clinical-grade reports for diagnostic laboratories. This enables precision medicine workflows and creates recurring revenue through subscription-based methylation profiling services for cancer diagnosis and prognosis.
Epigenomics and Chromatin Analysis Click to view more details →
CRISPR-Validated Target Identification and Ranking Platform
An integrated discovery platform combining CRISPR knockout screening data with genomics and transcriptomics to validate and rank targets by functional impact and therapeutic potential. Enables drug developers to confidently select targets with pre-validated biology, reducing downstream clinical attrition.
Genomics Drug Target Discovery Service Platforms Click to view more details →
Histone Modification Mapping Tools for Drug Discovery
Commercial software solutions integrate histone PTM data from multiple assays to predict gene expression changes and identify therapeutic targets in drug development pipelines. Pharmaceutical companies leverage these tools to accelerate lead compound identification and reduce time-to-market for epigenetic-based therapeutics.
Epigenomics and Chromatin Analysis Click to view more details →
Phenotype-Driven Genomic Target Discovery Enterprise Software
An enterprise SaaS platform that reverse-engineers disease phenotypes from genomic and clinical data to systematically identify actionable drug targets and patient biomarkers. Delivers white-label solutions and data-driven target intelligence to large pharma, generating annual recurring revenue through licensing agreements.
Genomics Drug Target Discovery Service Platforms Click to view more details →
Chromatin State Segmentation and Functional Annotation Platform
Cloud-based platforms automatically segment genomes into distinct chromatin states and functionally annotate regulatory elements using machine learning models trained on reference datasets. This delivers value through automated genome interpretation for synthetic biology applications and licensing partnerships with biotechnology enterprises.
Epigenomics and Chromatin Analysis Click to view more details →
Real-World Evidence Genomic Target Validation Marketplace
A digital marketplace and analytics platform that aggregates real-world clinical and genomic data to validate drug targets across diverse patient populations and disease subtypes. Monetizes through transaction fees, premium data access, and partnership agreements with pharmaceutical companies seeking robust target evidence.
Genomics Drug Target Discovery Service Platforms Click to view more details →
Real-Time Epigenetic Quality Control and Data Validation Systems
Integrated QC software monitors epigenomic experiment quality metrics in real-time, identifying batch effects and technical artifacts before data analysis begins. Service providers monetize through white-label licensing to sequencing centers and offer premium support tiers for high-throughput genomics facilities.
Epigenomics and Chromatin Analysis Click to view more details →
Structural Biology-Integrated Target Tractability Assessment Tool
A computational platform integrating protein structure prediction, binding pocket analysis, and chemical tractability scoring to assess druggability of genomic targets at scale. Provides pharmaceutical clients with pre-vetted, druggable target lists, commanding premium service fees for reduced development risk.
Genomics Drug Target Discovery Service Platforms Click to view more details →